Clinical and epidemiological overview of hyperacute ischemic stroke patients treated with intravenous thrombolysis

Abstract Background Hyperacute ischemic stroke is a type of ischemic stroke that occurs rapidly and suddenly due to blockage of blood flow to the brain, with onset within 0–24 h. The recommended treatment for hyperacute ischemic stroke patients is a recombinant tissue plasminogen activator (rtPA) ac...

Full description

Saved in:
Bibliographic Details
Main Authors: Lisda Amalia, Putri Qonitah
Format: Article
Language:English
Published: SpringerOpen 2025-02-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
Online Access:https://doi.org/10.1186/s43162-025-00419-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850190672167960576
author Lisda Amalia
Putri Qonitah
author_facet Lisda Amalia
Putri Qonitah
author_sort Lisda Amalia
collection DOAJ
description Abstract Background Hyperacute ischemic stroke is a type of ischemic stroke that occurs rapidly and suddenly due to blockage of blood flow to the brain, with onset within 0–24 h. The recommended treatment for hyperacute ischemic stroke patients is a recombinant tissue plasminogen activator (rtPA) according to the guidelines of the American Heart Association/American Stroke Association (AHA/ASA) and the European Stroke Organization (ESO). In Indonesia, there is still limited adoption of intravenous thrombolysis, and the researchers hope that hospitals in Indonesia will adopt this treatment for managing hyperacute ischemic stroke patients. Objective This study aims to describe the clinical characteristics of hyperacute ischemic stroke patients treated with intravenous thrombolysis. Methods This descriptive cross-sectional study was conducted at Dr. Hasan Sadikin Hospital in Bandung, which serves as the referral hospital for West Java for stroke cases treated with intravenous thrombolysis. The study employed total sampling from January 2021 to March 2024. Results From 23 patients, we found that most hyperacute ischemic stroke patients treated with intravenous thrombolysis were in the late elderly age group, 56–65 years old (43.5%), with onset within ≤ 4.5 h. Of the total sample, 91.3% of patients did not experience complications and approximately 50% of patients have good clinical and functional outcomes (based on NIHSS score). Conclusion This demonstrates the effectiveness of intravenous thrombolysis in managing hyperacute ischemic stroke patients. Future research should continue to explore optimal patient selection criteria and refine treatment protocols to further improve outcomes in stroke management.
format Article
id doaj-art-7ebd23543dc7468eb38c5ceb2dfc5d5e
institution OA Journals
issn 2090-9098
language English
publishDate 2025-02-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Internal Medicine
spelling doaj-art-7ebd23543dc7468eb38c5ceb2dfc5d5e2025-08-20T02:15:12ZengSpringerOpenThe Egyptian Journal of Internal Medicine2090-90982025-02-013711710.1186/s43162-025-00419-8Clinical and epidemiological overview of hyperacute ischemic stroke patients treated with intravenous thrombolysisLisda Amalia0Putri Qonitah1Padjadjaran UniversityPadjadjaran UniversityAbstract Background Hyperacute ischemic stroke is a type of ischemic stroke that occurs rapidly and suddenly due to blockage of blood flow to the brain, with onset within 0–24 h. The recommended treatment for hyperacute ischemic stroke patients is a recombinant tissue plasminogen activator (rtPA) according to the guidelines of the American Heart Association/American Stroke Association (AHA/ASA) and the European Stroke Organization (ESO). In Indonesia, there is still limited adoption of intravenous thrombolysis, and the researchers hope that hospitals in Indonesia will adopt this treatment for managing hyperacute ischemic stroke patients. Objective This study aims to describe the clinical characteristics of hyperacute ischemic stroke patients treated with intravenous thrombolysis. Methods This descriptive cross-sectional study was conducted at Dr. Hasan Sadikin Hospital in Bandung, which serves as the referral hospital for West Java for stroke cases treated with intravenous thrombolysis. The study employed total sampling from January 2021 to March 2024. Results From 23 patients, we found that most hyperacute ischemic stroke patients treated with intravenous thrombolysis were in the late elderly age group, 56–65 years old (43.5%), with onset within ≤ 4.5 h. Of the total sample, 91.3% of patients did not experience complications and approximately 50% of patients have good clinical and functional outcomes (based on NIHSS score). Conclusion This demonstrates the effectiveness of intravenous thrombolysis in managing hyperacute ischemic stroke patients. Future research should continue to explore optimal patient selection criteria and refine treatment protocols to further improve outcomes in stroke management.https://doi.org/10.1186/s43162-025-00419-8OnsetHyperacute ischemic strokeIntravenous thrombolysisNIHSS
spellingShingle Lisda Amalia
Putri Qonitah
Clinical and epidemiological overview of hyperacute ischemic stroke patients treated with intravenous thrombolysis
The Egyptian Journal of Internal Medicine
Onset
Hyperacute ischemic stroke
Intravenous thrombolysis
NIHSS
title Clinical and epidemiological overview of hyperacute ischemic stroke patients treated with intravenous thrombolysis
title_full Clinical and epidemiological overview of hyperacute ischemic stroke patients treated with intravenous thrombolysis
title_fullStr Clinical and epidemiological overview of hyperacute ischemic stroke patients treated with intravenous thrombolysis
title_full_unstemmed Clinical and epidemiological overview of hyperacute ischemic stroke patients treated with intravenous thrombolysis
title_short Clinical and epidemiological overview of hyperacute ischemic stroke patients treated with intravenous thrombolysis
title_sort clinical and epidemiological overview of hyperacute ischemic stroke patients treated with intravenous thrombolysis
topic Onset
Hyperacute ischemic stroke
Intravenous thrombolysis
NIHSS
url https://doi.org/10.1186/s43162-025-00419-8
work_keys_str_mv AT lisdaamalia clinicalandepidemiologicaloverviewofhyperacuteischemicstrokepatientstreatedwithintravenousthrombolysis
AT putriqonitah clinicalandepidemiologicaloverviewofhyperacuteischemicstrokepatientstreatedwithintravenousthrombolysis